Breakdown | Dec 2024 | Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 |
---|---|---|---|---|---|
Income Statement | |||||
Total Revenue | 24.03M | 34.62M | 18.90M | 23.43M | 25.69M |
Gross Profit | 12.07M | 26.50M | 13.94M | 18.37M | 21.53M |
EBITDA | -6.62M | -17.16M | -5.54M | 5.47M | 7.22M |
Net Income | -33.11M | -22.83M | -14.31M | 3.64M | 2.03M |
Balance Sheet | |||||
Total Assets | 354.23M | 390.20M | 414.44M | 441.76M | 439.51M |
Cash, Cash Equivalents and Short-Term Investments | 31.57M | 39.47M | 39.73M | 49.52M | 55.70M |
Total Debt | 1.21M | 248.25K | 1.48M | 239.74K | 1.65M |
Total Liabilities | 8.99M | 11.28M | 11.91M | 12.10M | 16.60M |
Stockholders Equity | 345.24M | 378.92M | 402.52M | 429.66M | 422.90M |
Cash Flow | |||||
Free Cash Flow | -6.33M | 1.61M | -5.18M | -5.84M | -1.22M |
Operating Cash Flow | -6.24M | 1.63M | -4.56M | -4.67M | -590.61K |
Investing Cash Flow | -93.30K | -25.46K | -617.01K | -1.17M | -632.24K |
Financing Cash Flow | -1.12M | -1.29M | -1.32M | -1.44M | -1.44M |
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
---|---|---|---|---|---|---|---|
62 Neutral | $16.85B | 11.50 | -7.38% | 2.96% | 1.59% | -23.36% | |
54 Neutral | €244.31M | ― | -17.37% | ― | -3.54% | -49.42% | |
52 Neutral | HK$147.48M | ― | -4.03% | ― | 12.86% | -269.71% | |
47 Neutral | HK$109.36M | ― | ― | -39.87% | 47.58% | ||
45 Neutral | HK$87.06M | ― | -9.14% | ― | -32.00% | -45.23% | |
44 Neutral | HK$55.74M | 14.86 | -1.07% | ― | 28.33% | 36.71% | |
34 Underperform | HK$156.60M | ― | -44.14% | ― | 15.79% | 17.72% |
Fujian Holdings Limited announced the successful passing of all resolutions at its Annual General Meeting held on May 30, 2025. The resolutions included the adoption of financial statements, re-election of directors, and granting mandates to the board for share allotment and repurchase, all of which received unanimous approval from shareholders.
Fujian Holdings Limited has announced its upcoming Annual General Meeting (AGM) scheduled for May 30, 2025, in Hong Kong. The meeting will cover the adoption of the company’s financial statements for 2024, the re-election of directors, and the appointment of auditors. Additionally, a resolution will be discussed to authorize the directors to issue new shares up to 20% of the existing share capital, potentially impacting the company’s capital structure and shareholder value.